After the different types of kidney cancer were disassembled for analysis, high levels of SLC7A11 remained significantly associated with poor prognosis in patients with ACC, KICH, KIRC, and KIRP, suggesting that SLC7A11 could be used as a potential biological marker for the prognostic evaluation of patients with various types of kidney cancer. Here, SLC7A11 is linked to kidney cancer.